Yubo International Biotech (YBGJ)
OTHER OTC:YBGJ
Total Valuation
Yubo International Biotech has a market cap or net worth of $1.62M. The enterprise value is $1.21M.
Market Cap$1.62M
Enterprise Value$1.21M
Share Statistics
Yubo International Biotech has 170,416,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding170,416,340
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Yubo International Biotech’s return on equity (ROE) is 0.55 and return on invested capital (ROIC) is 57.84%.
Return on Equity (ROE)0.55
Return on Assets (ROA)-1.27
Return on Invested Capital (ROIC)57.84%
Return on Capital Employed (ROCE)0.61
Revenue Per Employee7.47K
Profits Per Employee-59.96K
Employee Count18
Asset Turnover0.16
Inventory Turnover5.25
Valuation Ratios
The current PE Ratio of Yubo International Biotech is ―. Yubo International Biotech’s PEG ratio is 0.05.
PE Ratio―
PS Ratio12.88
PB Ratio-0.89
Price to Fair Value-0.89
Price to FCF-2.05
Price to Operating Cash Flow-3.05
PEG Ratio0.05
Income Statement
In the last 12 months, Yubo International Biotech had revenue of 134.39K and earned -1.08M in profits. Earnings per share was -0.01.
Revenue134.39K
Gross Profit8.16K
Operating Income-1.19M
Pretax Income-1.19M
Net Income-1.08M
EBITDA-1.02M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -434.28K and capital expenditures -4.00, giving a free cash flow of -434.29K billion.
Operating Cash Flow-434.28K
Free Cash Flow-434.29K
Free Cash Flow per Share>-0.01
Dividends & Yields
Yubo International Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.08
52-Week Price Change-71.70%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)99.95
Average Volume (3m)1.51K
Important Dates
Yubo International Biotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Yubo International Biotech as a current ratio of 0.24, with Debt / Equity ratio of -4.03%
Current Ratio0.24
Quick Ratio0.23
Debt to Market Cap0.05
Net Debt to EBITDA-0.07
Interest Coverage Ratio4.89K
Taxes
In the past 12 months, Yubo International Biotech has paid -108.69K in taxes.
Income Tax-108.69K
Effective Tax Rate0.09
Enterprise Valuation
Yubo International Biotech EV to EBITDA ratio is -1.77, with an EV/FCF ratio of -2.14.
EV to Sales13.41
EV to EBITDA-1.77
EV to Free Cash Flow-2.14
EV to Operating Cash Flow-2.14
Balance Sheet
Yubo International Biotech has $8.06K in cash and marketable securities with $78.78K in debt, giving a net cash position of -$70.72K billion.
Cash & Marketable Securities$8.06K
Total Debt$78.78K
Net Cash-$70.72K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.01
Margins
Gross margin is 6.08%, with operating margin of -883.76%, and net profit margin of -803.07%.
Gross Margin6.08%
Operating Margin-883.76%
Pretax Margin-883.94%
Net Profit Margin-803.07%
EBITDA Margin-759.43%
EBIT Margin0.00%
Analyst Forecast
The average price target for Yubo International Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―